We use cookies to ensure that we give you the best experience on our website.

If you continue without changing your settings, we’ll assume you’re happy to receive all cookies from the BMA website. Find out more about cookies

Your Privacy

When you visit any web site, it may store or retrieve information on your browser, mostly in the form of cookies. This information might be about you, your preferences or your device and is mostly used to make the site work as you expect it to. The information does not usually directly identify you, but it can give you a more personalised web experience.

Because we respect your right to privacy, you can choose not to allow some types of cookies. Click on the different category headings to find out more and change our default settings. However, blocking some types of cookies may impact your experience of the site and the services we are able to offer.

Strictly Necessary Cookies

(Req)

These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms.

You can set your browser to block or alert you about these cookies, but some parts of the site will not then work. These cookies do not store any personally identifiable information.

Continue

These cookies are required

Performance Cookies

These cookies allow us to know which pages are the most and least popular and see how visitors move around the site. All information we collect is anonymous unless you actively provide personal information to us.

If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.

Preferences Cookies

These cookies allow a website to remember choices you make (such as your user name, language or the region you're in) and tailor the website to provide enhanced features and content for you.

For example, they can be used to remember certain log-in details, changes you've made to text size, font and other parts of pages that you can customise. They may also be used to provide services you've asked for such as watching a video or commenting on a blog. These cookies may be used to ensure that all our services and communications are relevant to you. The information these cookies collect cannot track your browsing activity on other websites.

Without these cookies, a website cannot remember choices you've previously made or personalise your browsing experience meaning you would have to reset these for every visit. In addition, some functionality may not be available if this category is switched off.

3rd Party Cookies

Our websites sometimes integrate with other companies’ sites. For example, we integrate with social networking sites such as Twitter and Facebook, to make it easier for you to share what you have read. These sites place their own cookies on your browser as a result of us including their icons and ‘like’ or ‘share’ buttons on our sites.

Apply & close

NHS England plans to back tighter control on cancer drugs spending

What do you think - 

Should the onus be on drug companies to lower their prices? 

Or is this solution short-sighted, denying life-saving treatment to those in need? 

Let us know in the comments below. 

2 replies

  • Anonymous
    Anonymous
    I think the onus be on drug companies to lower their prices. There has to be a limit on how much individual patient treatments can cost the NHS - and I think the limit should be lower than it is now. Plus there are too many exceptions.

    One problem is that NICE does not have sufficient power and is often held over a barrel by the drug companies and patient groups with threats of, or actual, litigation. Also patient lobby groups sometimes have too much power to pressure NICE decisions and are often subsidised by the drug companies (yet this is not declared). NICE should be given more power to make decisions without risk of litigation from drug companies and patient lobby groups.
  • Anonymous
    Anonymous

    In reply to Anonymous:

    My treatment cost my husbands health insurance over 300,000. 10 years ago . To be honest I probably would not have survived on the nhs as I would not have got the treatments authourised quick enough . As it is I was told I was palliative then went into lasting remission. The mabs are good , and we need them but they are so very expensive . My treatment cost more than many peple earn in a decade . It is painfully unsustainable